WallStSmart

CLARIVATE PLC (CLVT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CLARIVATE PLC generates 848% more annual revenue ($2.46B vs $258.90M). CLVT leads profitability with a -8.2% profit margin vs -15.5%. CLVT earns a higher WallStSmart Score of 50/100 (C-).

CLVT

Buy

50

out of 100

Grade: C-

Growth: 2.7Profit: 3.5Value: 6.7Quality: 3.8
Piotroski: 5/9Altman Z: -0.19

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CLVT.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLVT2 strengths · Avg: 10.0/10
PEG RatioValuation
0.1810/10

Growing faster than its price suggests

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

CLVT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.61B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-4.0%2/10

ROE of -4.0% — below average capital efficiency

Revenue GrowthGrowth
-6.9%2/10

Revenue declined 6.9%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : CLVT

The strongest argument for CLVT centers on PEG Ratio, Price/Book. PEG of 0.18 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : CLVT

The primary concerns for CLVT are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

CLVT profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CLVT scores higher overall (50/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CLARIVATE PLC

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Clarivate Plc, an information services and analytics company, provides analysis and structured information for the discovery, protection and commercialization of scientific research, innovations and brands. The company is headquartered in London, the United Kingdom.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?